Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction

NCT00026819 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

NIH

Sponsor class

Conditions

Pain

Interventions

DRUG: Rofecoxib

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)